Novavax's vaccine, also produced by SII, found 90 pc effective against COVID-19 variants
Novavax's vaccine, also produced by SII, found 90 pc effective against COVID-19 variants
newKerala.com
0 shares
1 views
You might like
Related news coverage
Novavax COVID-19 vaccine shows over 90% efficacy in the U.S. late-stage trial
Invezz
Novavax Inc (NASDAQ: NVAX) said on Monday its candidate COVID-19 vaccine showed 93% efficacy in its U.S. late-stage trial. The..
Advertisement
More coverage
Novavax: Large study finds COVID-19 shot about 90 per cent effective
CTV News
Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large,..
-
Alert: Novavax says its vaccine is highly effective against COVID-19 in a large study and also protects against variants
SeattlePI.com
-
Novavax: Large study finds COVID-19 shot about 90% effective
SeattlePI.com
-
Novavax: Large study finds COVID-19 shot about 90% effective
Upworthy
-
Novavax COVID-19 vaccine more than 90% effective in US trial
Jerusalem Post